BLS-M22 ( DrugBank: BLS-M22 )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
113筋ジストロフィー1

113. 筋ジストロフィー


臨床試験数 : 646 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03789734
(ClinicalTrials.gov)
June 4, 201912/12/2018Safety Study of BLS-M22 in Healthy VolunteersA Dose Block-randomized, Double-blind, Placebo-controlled and Dose-escalation Phase I Clinical Trial to Evaluate Safety of BLS-M22 Following Single/Multiple Oral Administration in Healthy Adult VolunteersMuscular Dystrophy, DuchenneBiological: BLS-M22;Other: PlaceboBioLeaders CorporationNULLCompleted19 Years55 YearsAll37Phase 1Korea, Republic of